Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @lalaniMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @lalaniMD
-
Prikvačeni tweet
Thank you
@cgratzke for the opportunity to serve as Guest Editor for this issue of@EurUrolFocus -- made possible by
contributions from insightful colleagues:
"#Immunotherapy for Urinary & Rare#GU Cancers" https://www.eu-focus.europeanurology.com/current Editorial: https://authors.elsevier.com/a/1aMMj8Yy0LCfME … (1/2..)pic.twitter.com/NjcodflL6f
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Important trial from our former GU fellow
@lalaniMD that will help answer many questions! Congrats@lalaniMD@sebastienhotte@anilkapoormd#WCRM@AlbigesL@DrRanaMcKay@BradMcG04@Dominick_Bosse@ZiadBakounyhttps://twitter.com/lalanimd/status/1224827793072185344 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CYTOSHRINK trial is now open! Nice to see first-patient randomized today,
#WorldCancerDay
.
Thank you to our
multi-D collaborative team and, most importantly, #kidneycancer patients & their families. A.Swaminath@sebastienhotte@anilkapoormd et al. https://clinicaltrials.gov/ct2/show/NCT04090710 …pic.twitter.com/h6OAXbUZHn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Congrats to Dr. Tannir for receiving the
@MDAndersonNews Distinguished Clinical Faculty Mentor award. Inspiring acceptance speech on the importance of mentorship!@PavlosMsaouelpic.twitter.com/vq0pf2TgRh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Continuing to move the game forward
@KingJames. Much respect my brother
#33644Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Thank YOU
@lalaniMD@EurUrolFocus for inviting us! Great honor and a big pleasure!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Very nice work!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Thank you very much
@lalaniMD! It was an absolute pleasure to work with you on this review and to contribute to this important special issue of@EurUrolFocus with Ronan,@BraunMDPhD, &@DrChoueiri!@cgratzke@DanaFarberNews@DanaFarber@GustaveRoussy https://www.eu-focus.europeanurology.com/article/S2405-4569(19)30049-5/abstract … https://twitter.com/lalaniMD/status/1214994134823555072 …pic.twitter.com/ak7ytRlBy1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Thank you
@lalaniMD for your outstanding contribution as guest editor for@EurUrolFocus! Certainly one of our best issues!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Our real pleasure indeed, thanks
:-)https://twitter.com/lalaniMD/status/1214999403687301120 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
I totally agree w
@AbhiTrip87 It’s not only a pleasure but a great honor Thanks@EurUrolFocus@lalaniMD !Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
It’s was our pleasure to be able to contribute!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
Now Pembrolizumab approved in non-muscle invasive high-risk bladder cancer. First PD1 inh In this space
@ASCO @FDAOncology @BladderCancerUS @sonpavde @DanaFarber @BWHUrology http://m.email.asco.org/nl/jsp/m.jsp?c=%409O5aurJ3NSs2o9frPusbydtIBq3m%2FoSP0gpZ%2FEKOnYw%3D&cid=DM4213&bid=33777968 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Aly-Khan Lalani proslijedio/la je Tweet
The prospective clinical MSKCC NGS cohort is now >50,000 samples sequenced. Thanks to the hundreds of physicians, laboratory technicians, data scientists, nurses and support staff
@sloan_kettering who have made this initiative possible. A few thoughts on what we have learned.pic.twitter.com/9ra4tuqUg7
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
https://www.prnewswire.com/news-releases/bavencio-significantly-improved-overall-survival-in-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma-300981078.html … Press release states this first line maintenance study achieves OS in the ITT population (cisplatin eligable and inelgable) and is therefore distinct from front line atezo/pembro which are currently limited to biomarker positive cisplatin ineligable.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
My Top 10 GU Onc clinical advances/stories in 2019: RCC: 1) IO/VEGF: Pembro + Axi @ Ave + Axi (
@NEJM),@FDAOncology approval 2) IO role in sarcomatoid RCC and pembro role in non-clear cell RCC (KYN-427B), see poster disc session#GU19@ASCOPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Aly-Khan Lalani proslijedio/la je Tweet
This Viewpoint highlights current applications of
#microbiome science to human health and examines successes and remaining challengeshttps://ja.ma/377M5PdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aly-Khan Lalani proslijedio/la je Tweet
How ironic for
@NEJM to publish a systematic review on time-restricting eating and fasting for#ChristmasDay#diet https://www.nejm.org/doi/full/10.1056/NEJMra1905136?query=featured_home … by de Cabo and Mattson@HopkinsMedicinepic.twitter.com/o5FHhbIISv
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

all collaborators: